FILING ANALYSIS · THURSDAY, JUNE 11
Jaguar Health, Inc. JAGX — 8-K
negative
Jaguar Health, Inc. has entered into a common stock purchase agreement with an accredited investor, providing access to up to $40 million in funding, but this equity line of credit may lead to significant dilution for existing shareholders. The agreement allows the company to direct the investor to purchase shares at predetermined prices, subject to certain conditions, including a floor price of $
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →